Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Santosh Kumar Pandey"'
Autor:
Ravi Kant Chaturvedi, Santosh Kumar Pandey, Anshuman Tripathi, Laxmi Goparaju, Akhilesh Singh Raghubanshi, J. S. Singh
Publikováno v:
Frontiers in Plant Science, Vol 14 (2024)
Abiotic and biotic factors have considerable impact on the plasticity of plant functional traits, which influences forest structure and productivity; however, their inter-relationships have not been quantified for fragmented tropical dry forest (TDF)
Externí odkaz:
https://doaj.org/article/fb3e35087fca4a039a7424676ab6f834
Publikováno v:
Acta Palaeobotanica, Pp 32-41 (2021)
Angiosperms display striking variation of pollen morphological features within and between populations of the same species, as well as within individual plants. We describe and illustrate variation of pollen aperture number, which is called pollen he
Externí odkaz:
https://doaj.org/article/cd8f52761e6a407ca46d379aff16404f
Autor:
Ramakrishna Nirogi, Vijay Benade, Renny Abraham, Jagadeesh Babu Thentu, Surendra Petlu, Santosh Kumar Pandey, Rajesh Kumar Badange, Kumar Bojja, Ramkumar Subramanian
Publikováno v:
SLEEP. 46:A23-A25
Introduction Samelisant (SUVN-G3031) is a potent and selective histamine 3 receptor (H3R) inverse agonist with hH3 Ki of 8.7 nM. Samelisant exhibited desired pharmacokinetic properties and favorable brain penetration in rodents. Preclinical studies d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13112e7a6b38438e3260a8dd08a2cacb
https://doi.org/10.1093/sleep/zsad077.0051
https://doi.org/10.1093/sleep/zsad077.0051
Autor:
Ramakrishna Nirogi, Vijay Benade, Vinod Kumar Goyal, Santosh Kumar Pandey, Abdul Rasheed Mohammed, Anil Shinde, Dhanunjay Dogiparti, Jyothsna Ravula, Satish Jetta, Veera Raghava Chowdary Palacharla
Publikováno v:
Clinical Drug Investigation. 42:747-762
Ropanicant hydrochloride (previously known as SUVN-911, hereinafter referred to as ropanicant) is a novel alpha4 beta2 nicotinic acetylcholine receptor (α4β2 nAchR) antagonist being developed for the treatment of major depressive disorder. The obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b0a8cb608da7795f4cc3a4b2fbb5b9
https://doi.org/10.1007/s40261-022-01189-9
https://doi.org/10.1007/s40261-022-01189-9
Autor:
Vinod Kumar Goyal, Santosh Kumar Pandey, Vijay Benade, Anil K Shinde, Mohammed Abdul Rasheed, Rajesh Kumar Badange, Veera Raghava Chowdary Palacharla, Jyothsna Ravulu, Satish Jetta, Ramkumar Subramanian, Ramakrishna Nirogi
Publikováno v:
Alzheimer's & Dementia. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87841175477e2ee875eaaef6c88c935f
https://doi.org/10.1002/alz.062688
https://doi.org/10.1002/alz.062688
Autor:
Ramakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, Anil Shinde, Vinod Kumar Goyal, Satish Jetta, Jyothsna Ravula, Renny Abraham, Venkata Ramalingayya Grandhi, Ramkumar Subramanian, Santosh Kumar Pandey, Rajesh Kumar Badange, Abdul Rasheed Mohammed, Venkat Jasti, Clive Ballard, Jeffrey Cummings
Publikováno v:
International Journal of Geriatric Psychiatry. 37
The effects of masupirdine on the neuropsychiatric symptoms were explored.Masupirdine (SUVN-502) was evaluated for its effects on cognition in patients with moderate AD. The prespecified primary outcome showed no drug-placebo difference. Post hoc ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c1875b71599152ba90ab4d2f2a5e2b
https://doi.org/10.1002/gps.5813
https://doi.org/10.1002/gps.5813
Autor:
Ramakrishna Nirogi, Vinod Kumar Goyal, Vijay Benade, Ramkumar Subramanian, Jyothsna Ravula, Satish Jetta, Anil Shinde, Santosh Kumar Pandey, Pradeep Jayarajan, Venkat Jasti, Jeffrey Cummings
Publikováno v:
Neurology and therapy. 11(4)
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive deterioration in cognition, memory and activities of daily living. Selective blockade of serotonin-6 (5-HTThe efficacy and safety of masupirdine were evaluated in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0516acbb5991d8def5c116e945f0b33
https://pubmed.ncbi.nlm.nih.gov/35908254
https://pubmed.ncbi.nlm.nih.gov/35908254
Autor:
Santosh Kumar Pandey, Vinod Kumar Goyal, Veera Raghava Chowdary Palacharla, Abdul Rasheed Mohammed, Gopinadh Bhyrapuneni, Satish Jetta, Nageswara Rao Muddana, Ramakrishna Nirogi, Jyothsna Ravula
Publikováno v:
Clinical Drug Investigation. 41:469-482
SUVN-D4010 is a novel, potent, highly selective 5-HT4 partial agonist intended for the treatment of cognitive disorders. The objective of the clinical study was to characterize the safety, tolerability, and pharmacokinetics of SUVN-D4010 in healthy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af412d01403d5a9381d9223c5ca0f055
https://doi.org/10.1007/s40261-021-01027-4
https://doi.org/10.1007/s40261-021-01027-4
Autor:
Sujoy Chatterjee, Rajarshi Ghosh, Srirup Chatterjee, Santosh Kumar Pandey, Lakshmi Kumari Sankhyan, Satyajit Bose, Nikhil Bansal
Publikováno v:
Indian J Thorac Cardiovasc Surg
PURPOSE: Rheumatic heart disease is the most common acquired heart disease in children in developing countries. The heart valve lesions produce severe hemodynamic changes due to scarring of the valves over time. Around 15.6 million people are affecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584cc35d66bef7e60f0a72108af90dff
https://doi.org/10.1007/s12055-020-00925-0
https://doi.org/10.1007/s12055-020-00925-0
0265 Samelisant (SUVN-G3031), a Histamine H3 Receptor Inverse Agonist in Animal Models of Narcolepsy
Autor:
Vijay Benade, Renny Abraham, Raghava Chowdary Palacharla, Jagadeesh Babu Thentu, Surendra Petlu, Venkat Reddy Mekala, Santosh Kumar Pandey, Rajesh Kumar Badange, Kumar Bojja, Veena Reballi, Pramod Kumar Achanta, Praveen kumar Choudakari, Ramakrishna Nirogi
Publikováno v:
Sleep. 45:A119-A120
Introduction Samelisant (SUVN-G3031) is a potent and selective H3 receptor (H3R) inverse agonist with hKi of 8.7 nM. It lacks measurable affinity against 70 other targets which includes GPCRs, ion channels, transporters, enzymes, peptides, steroids,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8289b9c80733e9f562a7f1b40e9e7d30
https://doi.org/10.1093/sleep/zsac079.263
https://doi.org/10.1093/sleep/zsac079.263